ChEMBL
Creative Commons Attribution-Share Alike 3.0 Unported Licence | |
| Versioning | ChEMBL_28 |
|---|---|
ChEMBL or ChEMBLdb is a manually curated chemical database of bioactive molecules with drug inducing properties.[1] It is maintained by the
The database, originally known as StARlite, was developed by a biotechnology company called Inpharmatica Ltd. later acquired by Galapagos NV. The data was acquired for EMBL in 2008 with an award from The Wellcome Trust,[2] resulting in the creation of the ChEMBL chemogenomics group at EMBL-EBI, led by John Overington.[3][4]
Scope and access
The ChEMBL database contains compound bioactivity data against drug targets. Bioactivity is reported in Ki, Kd, IC50, and EC50.[5] Data can be filtered and analyzed to develop compound screening libraries for lead identification during drug discovery.[6]
ChEMBL version 2 (ChEMBL_02) was launched in January 2010, including 2.4 million bioassay measurements covering 622,824 compounds, including 24,000 natural products. This was obtained from curating over 34,000 publications across twelve medicinal chemistry journals. ChEMBL's coverage of available bioactivity data has grown to become "the most comprehensive ever seen in a public database.".[3] In October 2010 ChEMBL version 8 (ChEMBL_08) was launched, with over 2.97 million bioassay measurements covering 636,269 compounds.[7]
ChEMBL_10 saw the addition of the
ChEMBLdb can be accessed via a web interface or downloaded by File Transfer Protocol. It is formatted in a manner amenable to computerized data mining, and attempts to standardize activities between different publications, to enable comparative analysis.[1] ChEMBL is also integrated into other large-scale chemistry resources, including PubChem and the ChemSpider system of the Royal Society of Chemistry.
Associated resources
In addition to the database, the ChEMBL group have developed tools and resources for data mining.
GPCR SARfari is a similar workbench focused on
July 2012 saw the release of a new malaria data service Archived 2016-07-30 at the Wayback Machine, sponsored by the Medicines for Malaria Venture (MMV), aimed at researchers around the globe. The data in this service includes compounds from the Malaria Box screening set, as well as the other donated malaria data found in ChEMBL-NTD.
myChEMBL, the ChEMBL virtual machine, was released in October 2013 to allow users to access a complete and free, easy-to-install cheminformatics infrastructure.
In December 2013, the operations of the SureChem patent informatics database were transferred to EMBL-EBI. In a portmanteau, SureChem was renamed SureChEMBL.
2014 saw the introduction of the new resource ADME SARfari - a tool for predicting and comparing cross-species ADME targets.[10]
See also
References
- ^ PMID 21948594.
- ^ "Open access drug discovery database launches with half a million compounds | Wellcome". wellcome.ac.uk. 18 January 2010. Retrieved 31 August 2019.
- ^ .
- S2CID 2946417.
- PMID 21978256.
- PMID 18064617.
- ^ ChEMBL-og (15 November 2010), ChEMBL_08 Released, retrieved 15 November 2010
- ^ ChEMBL-og (6 June 2011), ChEMBL_10 Released, retrieved 9 June 2011
- PMID 21936816.
- PMID 25964657.
External links
ChEMBL ID (P592) (see uses)
- ChEMBLdb
- Kinase SARfari Archived 2016-05-15 at the Wayback Machine
- ChEMBL-Neglected Tropical Disease Archive
- GPCR SARfari
- The ChEMBL-og Open data and drug discovery blog run by the ChEMBL team.
| Centres and institutes |
|  | ||||
|---|---|---|---|---|---|---|
| Projects and facilities |
| |||||
| Board of governors | ||||||
| Executive leadership team |
| |||||
| Former directors |
| |||||
| Other key people | ||||||
| Awards and fellowships |
| |||||
